{"chunk_id": "Integrated Maternal and Perinatal Care Guideline_23_10_2024_0__chunk_322", "source": "Integrated Maternal and Perinatal Care Guideline_23_10_2024_0", "text": "ntibody protection for the newborn against tetanus, diphtheria and pertussis (whooping\ncough)\no Aim to administer a dose of Tdap during each pregnancy irrespective of the patient’s prior history of\nreceiving Tdap.\n To maximize the maternal antibody response and passive antibody transfer to the infant,\noptimal timing for Tdap administration is between 27 and 36 weeks of gestation although Tdap\nmay be given at any time during pregnancy or postpartum\n Administer intramuscularly, preferably in the"}